subtopbanner.gif (6758 bytes)

Back To Conference Page Home Page







 

 

NEUROTOXICOLOGY 24

Twenty-Fourth International Neurotoxicology Conference

Location

Holiday Inn Riverwalk, San Antonio, Texas, USA

Event Starts On

November 11, 2007

Event Ends On

November 14, 2007

Organizer

Joan M. Cranmer, Professor of Pediatrics and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences

Website/Program

Visit   www.neurotoxicology.com

 

Important Dates

Abstract platform Deadline

September 10, 2007

Abstract poster Deadline

October 1, 2007

Discounted Conference Registration Deadline

October 1, 2007

Discounted Hotel Rate Deadline

October 10, 2007

Deadline to Submit your Paper for Peer-Reviewed Special Issue of NeuroToxicology

February 1, 2008

 

Background and Rationale

Scope

'Environmental Etiologies of Neurological Disorders - Modifiers of Risk: Genes, Age, Gender, Nutrition, Simultaneous Exposures, Socio-Economic Issues'

Background and Rationale: Environmental Etiologies of Neurological Disorders: Modifiers of Risk: Genes, Age, Gender, Nutrition, Simultaneous Exposures, Socio-Economic Status. It has become increasingly evident that many human neurological diseases and disorders arise from complex interactions of multiple risk factors, of which environmental chemical exposures may serve as one contributing risk. Other environmental and host factors, such as genetic background, stage of development, dietary status, immune status, obesity, stress, socioeconomic status, gender, aging, behavior, and intercurrent disease state, as well as simultaneous chemical exposures, can also contribute. For example, Parkinson’s disease exhibits gender differences, and protection is conferred by caffeine and smoking. The impact of neurotoxicants like lead and methylmercury is heavily influenced by developmental windows, with children showing significantly greater vulnerability. Thus, a full understanding of the true risk posed by any environmental toxicant for human neurological diseases or disorders will ultimately require assessments of its interaction with other relevant environmental, host and genetic risk factors and other modifiers of effect.

Despite these complexities, the paradigms used to understand the impact of environmental exposures as risk factors for human diseases continue to rely on approaches that fail to capture this reality. Instead, they focus on exposures to single chemicals in isolation from other risk factors. Animal studies often examine effects of a single chemical in young adult, mostly male rodents, ignoring, for instance, the potential importance of age and gender. Epidemiological and clinical studies generally focus on main effects of environmental exposures, since risk modification, as reflected in statistical interactions, is considered inaccessible because of inadequate sample sizes. Consequently, as models of diseases and disorders, current research approaches are distant from actual human conditions, constraining the ability to determine pathophysiological mechanisms from which biomarkers and therapeutic strategies can be identified, thereby limiting the ability to protect human health.

An understanding of the interactions of host and environmental risk factors with environmental chemical exposures in the etiology of neurological diseases and disorders allows the development of increasingly more realistic and valid animal models of disease, and more focused clinical /epidemiological studies. Refined animal and human models will expedite the discovery of pathophysiological mechanisms of environmentally-related diseases and disorders, and thus improve the ability to define biomarkers of disease onset and progression, as well as potential targets for therapeutic interventions, thereby leading to improved prevention and detection strategies. Understanding how risk factors interact is also critical in the context of global public health protection, since different populations and cultures bring different sets of risk factors into play.

Focus Topics

 

Disease or Disorders:

·  Parkinson disease

·  Toxicant-Induced Cognitive Disorders

·  Alzheimer disease

·  ADHD

·  Autism

·  ALS


Risk Modifiers:

·  Genes

·  Age

·  Gender

·  Nutrition

·  Extended Environment (Social/Political/ Economic)

·  Co-Exposures

Case Studies:

·  Lead

·  Pesticides

·  Mercury

·  Mn

·  PCBs

Research Approach:

·  Translational

·  Integrated

·  Multifactorial

·  Interdisciplinary

·  Outreach

Call for Abstracts   

For complete details and form go to www.neurotoxicology.com

E-mail your abstract to Leslie A. Lang Hicks. The information on the form must be included with Abstract Submission! Notification of presentation from platform or poster will be by e-mail using the e-mail address shown on your abstract form.

Submission/Contact Address

Submission/Contact Address

Dr. Joan M. Cranmer (Conference Chair)
Editor-in-Chief, NeuroToxicology
Professor of Pediatrics and Toxicology
Department of Pediatrics
University of Arkansas for Medical Sciences
1120 Marshall - Room 6007
Little Rock, AR 72202-3591
Tel: 501-364-2986
Fax: 501-364-4978
Email: cranmerjoanm@uams.edu

Leslie A. Lang Hicks
Conference Administrator
Editorial Assistant, NeuroToxicology
Department of Pediatrics
University of Arkansas for Medical Sciences
1120 Marshall Street- Room 6007
Little Rock, AR 72202
Tel: 501-364-3604
Fax: 501-364-4978
Email: langlesliea@uams.edu

Poster Session

Posters on any aspect of toxicology/neuroscience/public health are welcome. 

Poster Size:  4 feet high x 6 feet wide

Check www.neurotoxicology.com for updates

 

Posters do not need to be related to the theme.  Posters on any aspect of toxicology/neuroscience/public health are welcome

Additional Information about the event

Student Awards:
Students are encouraged to submit an abstract and compete for the Pre- and Post-Doctoral Student Award. Presentations will be from poster.

Student awards are judged during the poster session.

Register Online for Conference & Hotel

For conference registration questions, please contact

Jackie Jagers, Registrar

The Neurotoxicology Conference
Arkansas Children’s Hospital
800 Marshall Street- Slot 682
Little Rock, AR 72202-3591 USA
Tel: (501) 364 - 1248
Fax: (501) 364 - 3892
Email: jagersjf@archildrens.org

 

 

Publication Details

Name

International Journal NeuroToxicology

Language of Publication

English

Medium of Publication

Full Text

Additional Information about Publication

Abstracts will be included in an Abstract Booklet in the conference packet and also published in the international journal NeuroToxicology.

Website

http://www.neurotoxicology.com/

 

Sponsors (as of 8/15/07). 

The Neurotoxicology Conference is seeking Sponsors to make this meeting a great success.  Sponsorship Opportunities are posted on the website.

 

Diamond  

National Institute of Environmental Health Sciences

  • Environmental and Occupational Health Sciences Institute/UMDNJ & Rutgers

 

Platinum 

  • Environmental Protection Agency
  • March of Dimes Birth Defects Foundation
  • Autism Society of America
  • Agency for Toxic Substances and Disease Registry
  • Autism Speaks

 

Gold  

  • Elsevier Publishers ~ Amsterdam 
  • Charles River DDS - Argus Division
  • The John Merck Fund
  • Toxipedia

 

Silver  

  • Arkansas Children’s Hospital
  • The Hamner Institutes for Health Sciences

Society of Toxicology

  • Institute for Children’s Environmental Health
  • Institute of Neurotoxicology & Neurological Disorders
  • Center for Toxicology & Environmental Health
  • World Health Organization

 

 

Educational Partner

  • The University of Arkansas for Medical Sciences
  • The University of Texas Health Science Center at San Antonio
  • The Sam & Ann Barshop Institute
  • VA Research & Development

 

subspacer.gif (59 bytes)

   

 

subbottomwhole.gif (3428 bytes)